Anderson, Matt S <br/><br/>
Effects of Rifampin, a potent inducer of drug-metabolizing enzymes and an inhibitor of OATP1B1/3 transport, on the single dose pharmacokinetics of anacetrapib.  [electronic resource] 

 -  Journal of clinical pharmacology  Jul 2013 
 - 746-52 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1552-4604 
<br/><br/><label>Standard No.: </label>10.1002/jcph.97  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Area Under Curve<br/>Cytochrome P-450 CYP3A--metabolism<br/>Drug Interactions<br/>Female<br/>Humans<br/>Inactivation, Metabolic<br/>Liver-Specific Organic Anion Transporter 1<br/>Male<br/>Middle Aged<br/>Organic Anion Transporters--antagonists & inhibitors<br/>Organic Anion Transporters, Sodium-Independent--antagonists & inhibitors<br/>Oxazolidinones--administration & dosage<br/>Rifampin--adverse effects<br/>Solute Carrier Organic Anion Transporter Family Member 1B3<br/>Young Adult